HONOLULU, HI—Fentanyl sublingual spray can be safely titrated to an effective dose in patients with breakthrough cancer pain, a study presented at the American Pain Society’s 31 st Annual Scientific ...
DALLAS, June 08, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL), an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of ...
HONOLULU, HI—Fentanyl sublingual spray is generally safe and well tolerated for long-term use in opioid-tolerant patients with cancer for the treatment of breakthrough pain, study investigators at the ...
May 25, 2012 (Honolulu, Hawaii) — Patients experiencing breakthrough cancer pain fared best on relatively high doses of sublingual fentanyl spray, a new study shows. The recently introduced sublingual ...
Nurses at West Cancer Center in Memphis, Tennessee, developed a best nursing practice protocol for titration of fentanyl sublingual spray (FSS; Subsys) for breakthrough cancer pain. Studies show that ...
Rapid epinephrine absorption with a time to reach the 100 pg/mL threshold concentration in 9 minutes after dosing Sustained pharmacokinetics (PK) with plasma epinephrine concentration remaining above ...
PHOENIX, AZ--(Mar 26, 2012) - INSYS Therapeutics, Inc. (PINKSHEETS: NEOL) announces the launch of SUBSYS™ (fentanyl sublingual spray) indicated for the management of breakthrough pain in cancer ...
January 5, 2012 — Insys Therapeutics today announced that the US Food and Drug Administration (FDA) has granted approval for Subsys, a fentanyl sublingual spray for the treatment of breakthrough ...
INSYS Therapeutics Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray
PHOENIX, March 9 /PRNewswire/ -- INSYS Therapeutics, Inc. announces positive results from the pivotal phase III efficacy trial for patients utilizing the Fentanyl Sublingual Spray (SL Spray) ...
To test the effect on satiety of a formulation comprising plant extracts naturally containing 5-hydroxytryptophan, delivered as sublingual spray (5HTP-Nat Exts), administered five times a day for 2 ...
Insys Therapeutics has launched Subsys fentanyl sublingual spray to manage recurring cancer pain, according to Pharmaceutical Business Review. The spray is available in 100mcg through 1600mcg doses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback